GANX vs MAS · $53.0M cap vs P/E 18, rev $7.56B
Gain Therapeutics Inc (GANX) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
Gain Therapeutics Inc (GANX) is a biotechnology company listed on US.
Masco Corporation (MAS) is a building products & equipment company listed on US.
GANX does not have a complete income-statement cache yet.
Latest reported MAS revenue for 2025-12-31 was $7.56B. Net income was $810.0M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
GANX currently screens at market cap $53.0M. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the GANX and MAS stock pages for the full models.
Not investment advice.